Out of 189 DLBCL cases, 26% exhibited 10–100% TRPM4-positive tumor cells, and the high TRPM4 expression in activated B cell-like DLBCL subtype was associated with a reduced overall and progression-free survival [188]. Here, TRPM4 is linked to diffuse large B-cell lymphoma.